Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea

First clinical sites approved and actively screening potential participants Represents another major milestone in the advancement of IHL-42X towards Phase III development IHL-42X has received FDA Fast Track designation, highlighting its potential to address the significant unmet medical need in